Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: June 23, 2017
What are the generic sources for potassium chloride and what is the scope of potassium chloride patent protection?
Potassium chloride is the generic ingredient in thirty-nine branded drugs marketed by Fresenius Kabi Usa, Lupin Ltd, Baxter Hlthcare, Abraxis Pharm, Actavis Labs Fl Inc, Hospira, Upsher-smith Labs, Watson Labs, Kremers Urban Pharms, Lehigh Valley, Copley Pharm, Pharma Res Software, Gd Searle Llc, Luitpold, Upsher Smith Labs, Savage Labs, Amneal Pharms, Novel Labs Inc, Sigmapharm Labs Llc, Teva, Nesher Pharms, Schering, Tris Pharma Inc, PII, Apothecon, Kv Pharm, Icu Medical Inc, Pharma Serve Ny, Glenmark Pharms Ltd, Mylan Pharms Inc, Intl Medication, Adare Pharms Inc, Lilly, B Braun, Novartis, Abbvie, Paddock Llc, Anchen Pharms, Akorn, Miles, and Future Pak, and is included in eighty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.| Tradenames: | 39 |
| Patents: | 1 |
| Applicants: | 41 |
| NDAs: | 80 |
| Drug Master File Entries: see list | 227 |
| Suppliers / Packagers: see list | 73 |
| Bulk Api Vendors: see list | 127 |
| Clinical Trials: see list | 963 |
| Therapeutic Class: | Therapeutic Nutrients/Minerals/Electrolytes |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | potassium chloride at DailyMed |
| Ingredient-type | Potassium Compounds |
| Drug Class | Potassium Salt Osmotic Laxative |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
| Applicant | Application No. | Strength | Dosage Form |
| ► Subscribe | ► Subscribe | 20MEQ | Tablet; Oral |
| ► Subscribe | ► Subscribe | 10MEQ | Tablet, Extended Release; Oral |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Miles | POTASSIUM CHLORIDE | potassium chloride | INJECTABLE;INJECTION | 080195-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Sigmapharm Labs Llc | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 207528-001 | Aug 19, 2016 | AB2 | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Glenmark Pharms Ltd | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 203562-002 | Jul 26, 2016 | AB1 | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Glenmark Pharms Ltd | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 203562-001 | Jul 26, 2016 | AB1 | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Teva | POTASSIUM CHLORIDE | potassium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 073531-001 | Apr 26, 1996 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 019439-001 | Jun 13, 1986 | 4,863,743 | ► Subscribe | ||||||||||||||||||||||
Kv Pharm | MICRO-K LS | potassium chloride | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 019561-003 | Aug 26, 1988 | 4,259,315 | ► Subscribe | ||||||||||||||||||||||
Nesher Pharms | MICRO-K | potassium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 018238-001 | Approved Prior to Jan 1, 1982 | 4,259,315 | ► Subscribe | ||||||||||||||||||||||
Apothecon | KLOTRIX | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 017850-001 | Approved Prior to Jan 1, 1982 | 4,140,756 | ► Subscribe | ||||||||||||||||||||||
Schering | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 019439-002 | Jun 13, 1986 | 4,863,743 | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
Join the 21,675 other biopharmaceutical professionals who get our Drug Patent Expiration Alerts:
